PATENT CLAIM ANALYSIS

Application Number: 16132300
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "250000"]

Abstract:
The present invention is directed to methods of treating tuberculosis by providing a pharmaceutically effective amount of a combination of drug compounds.

Claim (Index 3):
The pharmaceutical composition of  claim 1 , wherein the composition consists of a pharmaceutically effective amount of the combination of (a) clofazimine, (b) bedaquiline, (c) pyrazinamide, and (d) SQ109.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 97.0
- Lexical Diversity: 1.15
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15523906', '13942342', '15409911', '16087161', '12255976']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7672263335080818
- 35 USC 102 Novelty (BERT): 0.688974578585951
- Combined Prediction Score: 0.7594011580158687
- Mean Citation Score: 424.417446
- Max Citation Score: 817.9278
- Similarity Product: 655.5069908535004

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test